Carlson Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,600	Closed	-$775K	–	59
2024 Q4	$775K	Buy	+8,600	New	+$833K	0.46%	16
2024 Q1	–	Sell	-53,000	Closed	-$4.73M	–	160
2023 Q4	$4.73M	Sell	53,000 -33,400	-39%	-$2.48M	0.38%	71
2023 Q3	$6.31M	Buy	86,400 +24,000	+38%	+$1.92M	0.49%	60
2023 Q2	$5.19M	Sell	62,400 -4,900	-7%	-$410K	0.44%	65
2023 Q1	$5.13M	Buy	+67,300	New	+$5.58M	0.48%	56
2022 Q3	–	Sell	-39,900	Closed	-$2.96M	–	148
2022 Q2	$2.96M	Sell	39,900 -11,100	-22%	-$833K	0.21%	91
2022 Q1	$4.58M	Sell	51,000 -3,000	-6%	-$277K	0.31%	85
2021 Q4	$6.05M	Buy	54,000 +21,200	+65%	+$2.56M	0.35%	68
2021 Q3	$4.12M	Buy	32,800 +900	+3%	+$116K	0.22%	104
2021 Q2	$4.32M	Buy	+31,900	New	+$4.19M	0.21%	95